Please sign in to follow a disease.

Langer mesomelic dysplasia

MONDO:0009588

Langer mesomelic dysplasia (LMD) is characterized by severe disproportionate short stature with mesomelic and rhizomelic shortening of the upper and lower limbs.

Also known as: Langer mesomelic dysplasia, Langer syndrome, Langer type mesomelic dysplasia, langer mesomelic dysplasia, pseudoautosomal recessive, mesomelic dwarfism, Langer type, LMD, dyschondrosteosis, homozygous, mesomelic dwarfism of the hypoplastic ulna, fibula and mandible type

2 clinical trials for this condition and its sub-types, 2 tagged with Langer mesomelic dysplasia itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Mesomelic dysplasia (2)

Including sub-types (2) Tagged with Langer mesomelic dysplasia (2)

Trials to join now! 1 Not yet finished but already full! 1

New drug shows promise for brain tumors from breast and lung cancer

Disease control Ongoing

This study tests a drug called QBS72S in 21 adults with breast or lung cancer that has spread to the brain. The drug is given once a month through an IV. The main goal is to see if it shrinks brain tumors. The trial is active but not recruiting new participants.

Phase 2 • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

Langer mesomelic dysplasia

Where it sits in the disease tree

New drug shows promise for brain tumors from breast and lung cancer